Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2021 Filed May 21, 2021 20:38 UTC |
snyderman nancy lynn MDDirector
|
Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017790 · form4.xml · nonDerivative · entry 1 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:35 UTC |
GAYNOR RICHARDDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017788 · form4.xml · derivative · entry 3 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F1 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:35 UTC |
GAYNOR RICHARDDirector
|
Tax withholdingOrdinary Shares | 1,404 | $21.92 | $30,775.68 |
DisclosureSEC source: 0001127602-21-017788 · form4.xml · nonDerivative · entry 2 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:35 UTC |
GAYNOR RICHARDDirector
|
Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017788 · form4.xml · nonDerivative · entry 1 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:34 UTC |
Cooke ShaneDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017785 · form4.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F1 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:34 UTC |
Cooke ShaneDirector
|
Tax withholdingOrdinary Shares | 3,175 | $21.92 | $69,596.00 |
DisclosureSEC source: 0001127602-21-017785 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,801 Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:34 UTC |
Cooke ShaneDirector
|
Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017785 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 19, 2021 20:27 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-017397 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 150,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| May 18, 2021 Filed May 19, 2021 20:27 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
SaleOrdinary Shares | 150,000 | $21.90 | $3,285,405.00 |
DisclosureSEC source: 0001127602-21-017397 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 792,040 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.76 to $22.05. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| May 18, 2021 Filed May 19, 2021 20:27 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionOrdinary Shares | 150,000 | $18.11 | $2,715,750.00 |
DisclosureSEC source: 0001127602-21-017397 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 942,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:26 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-017395 · form4.xml · derivative · entry 3 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 50,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:26 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
SaleOrdinary Shares | 50,000 | $22.09 | $1,104,650.00 |
DisclosureSEC source: 0001127602-21-017395 · form4.xml · nonDerivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,781 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.98 to $22.25. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:26 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 50,000 | $18.11 | $905,250.00 |
DisclosureSEC source: 0001127602-21-017395 · form4.xml · nonDerivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 14, 2021 Filed May 14, 2021 20:47 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-016869 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,250 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| May 14, 2021 Filed May 14, 2021 20:47 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
SaleOrdinary Shares | 2,250 | $22.23 | $50,017.50 |
DisclosureSEC source: 0001127602-21-016869 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,597 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 14, 2021 Filed May 14, 2021 20:47 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 2,250 | $18.11 | $40,736.25 |
DisclosureSEC source: 0001127602-21-016869 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 13, 2021 Filed May 14, 2021 16:46 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-016868 · form4.xml · derivative · entry 3 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 25,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 13, 2021 Filed May 14, 2021 16:46 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
SaleOrdinary Shares | 25,000 | $22.39 | $559,695.00 |
DisclosureSEC source: 0001127602-21-016868 · form4.xml · nonDerivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,781 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.23 to $22.65. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| May 13, 2021 Filed May 14, 2021 16:46 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 25,000 | $18.11 | $452,625.00 |
DisclosureSEC source: 0001127602-21-016868 · form4.xml · nonDerivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:24 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-016394 · form4.xml · derivative · entry 4 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Ordinary Shares · 150,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:24 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
SaleOrdinary Shares | 60,297 | $22.30 | $1,344,797.96 |
DisclosureSEC source: 0001127602-21-016394 · form4.xml · nonDerivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 792,040 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.25 to $22.38. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:24 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
SaleOrdinary Shares | 89,703 | $21.95 | $1,968,541.31 |
DisclosureSEC source: 0001127602-21-016394 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852,337 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.25 to $22.24. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:24 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionOrdinary Shares | 150,000 | $18.11 | $2,715,750.00 |
DisclosureSEC source: 0001127602-21-016394 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 942,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 07, 2021 Filed May 7, 2021 16:48 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 19,477 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-015896 · form4.xml · derivative · entry 3 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Ordinary Shares · 19,477 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 07, 2021 Filed May 7, 2021 16:48 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
SaleOrdinary Shares | 19,477 | $22.10 | $430,521.56 |
DisclosureSEC source: 0001127602-21-015896 · form4.xml · nonDerivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,781 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.97 to $22.42. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| May 07, 2021 Filed May 7, 2021 16:48 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 19,477 | $18.11 | $352,631.09 |
DisclosureSEC source: 0001127602-21-015896 · form4.xml · nonDerivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 06, 2021 Filed May 7, 2021 20:47 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-015894 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Ordinary Shares · 100,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| May 06, 2021 Filed May 7, 2021 20:47 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
SaleOrdinary Shares | 100,000 | $21.79 | $2,179,410.00 |
DisclosureSEC source: 0001127602-21-015894 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 792,040 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.54 to $22.16. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| May 06, 2021 Filed May 7, 2021 20:47 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionOrdinary Shares | 100,000 | $18.11 | $1,810,500.00 |
DisclosureSEC source: 0001127602-21-015894 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 892,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:17 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 34,503 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-015189 · form4.xml · derivative · entry 3 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 34,503 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:17 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
SaleOrdinary Shares | 34,503 | $22.18 | $765,155.78 |
DisclosureSEC source: 0001127602-21-015189 · form4.xml · nonDerivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,154 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.55. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:17 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 34,503 | $18.11 | $624,676.82 |
DisclosureSEC source: 0001127602-21-015189 · form4.xml · nonDerivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 19:22 UTC |
DIXON WENDY LDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $14.60 | $0.00 |
DisclosureSEC source: 0001127602-21-014126 · form4.xml · derivative · entry 3 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,000 shares Expires 2021-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 19:22 UTC |
DIXON WENDY LDirector
|
SaleOrdinary Shares | 25,000 | $20.00 | $500,120.00 |
DisclosureSEC source: 0001127602-21-014126 · form4.xml · nonDerivative · entry 2 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,600 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.04. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 19:22 UTC |
DIXON WENDY LDirector
|
Exercise / conversionOrdinary Shares | 25,000 | $14.60 | $365,000.00 |
DisclosureSEC source: 0001127602-21-014126 · form4.xml · nonDerivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 23:20 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 34,792 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-014125 · form4.xml · derivative · entry 6 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 34,792 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 23:20 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
SaleOrdinary Shares | 34,792 | $20.00 | $695,759.98 |
DisclosureSEC source: 0001127602-21-014125 · form4.xml · nonDerivative · entry 4 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,362 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.99 to $20.04. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 23:20 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 34,792 | $18.11 | $629,909.16 |
DisclosureSEC source: 0001127602-21-014125 · form4.xml · nonDerivative · entry 3 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 23:20 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 208 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-21-014125 · form4.xml · derivative · entry 5 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,792 Underlying: Ordinary Shares · 208 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 23:20 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
SaleOrdinary Shares | 208 | $19.99 | $4,157.92 |
DisclosureSEC source: 0001127602-21-014125 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,362 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 23:20 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 208 | $18.11 | $3,765.84 |
DisclosureSEC source: 0001127602-21-014125 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:35 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
SaleOrdinary Shares | 28,920 | $19.72 | $570,287.94 |
DisclosureSEC source: 0001127602-21-013891 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.32 to $19.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:59 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 342,187 | $0.00 Strike: $19.73 | $0.00 |
DisclosureSEC source: 0001127602-21-007797 · form4.xml · derivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,187 Underlying: Ordinary Shares · 342,187 shares Expires 2031-02-22 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:56 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
GrantRestricted Stock Unit Award · Derivative | 27,877 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007796 · form4.xml · derivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,877 Underlying: Ordinary Shares · 27,877 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:56 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 113,754 | $0.00 Strike: $19.73 | $0.00 |
DisclosureSEC source: 0001127602-21-007796 · form4.xml · derivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,754 Underlying: Ordinary Shares · 113,754 shares Expires 2031-02-22 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 20:56 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 22,175 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007795 · form4.xml · derivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,175 Underlying: Ordinary Shares · 22,175 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 20:56 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 90,487 | $0.00 Strike: $19.73 | $0.00 |
DisclosureSEC source: 0001127602-21-007795 · form4.xml · derivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,487 Underlying: Ordinary Shares · 90,487 shares Expires 2031-02-22 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:55 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
GrantRestricted Stock Unit Award · Derivative | 38,014 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007794 · form4.xml · derivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,014 Underlying: Ordinary Shares · 38,014 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:55 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 155,119 | $0.00 Strike: $19.73 | $0.00 |
DisclosureSEC source: 0001127602-21-007794 · form4.xml · derivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,119 Underlying: Ordinary Shares · 155,119 shares Expires 2031-02-22 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:54 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantRestricted Stock Unit Award · Derivative | 48,151 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007793 · form4.xml · derivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,151 Underlying: Ordinary Shares · 48,151 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.